Interestingly, methylation of WIF1 has been demonstrated as an independent outcome predictor with a negative impact on patient prognosis in different cancers, including leukemia, lung cancer, breast cancer, and colon cancer47–50. Here, WIF1 is linked to breast carcinoma.